25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SyntekaBio Inc
Buy, Hold or Sell?

Let's analyze Syntekabio together

I guess you are interested in SyntekaBio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SyntekaBio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SyntekaBio Inc

I send you an email if I find something interesting about SyntekaBio Inc.

1. Quick Overview

1.1. Quick analysis of Syntekabio (30 sec.)










1.2. What can you expect buying and holding a share of Syntekabio? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,073.02
Expected worth in 1 year
₩1,811.76
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
₩-261.26
Return On Investment
-4.1%

For what price can you sell your share?

Current Price per Share
₩6,420.00
Expected price per share
₩4,195 - ₩7,940
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Syntekabio (5 min.)




Live pricePrice per Share (EOD)
₩6,420.00

2.2. Growth of Syntekabio (5 min.)




Is Syntekabio growing?

Current yearPrevious yearGrowGrow %
How rich?$22.1m$21.7m$3.2m12.9%

How much money is Syntekabio making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$1.9m$670.7k51.7%
Net Profit Margin72,024.2%-38,724.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Syntekabio (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Syntekabio?

Welcome investor! Syntekabio's management wants to use your money to grow the business. In return you get a share of Syntekabio.

First you should know what it really means to hold a share of Syntekabio. And how you can make/lose money.

Speculation

The Price per Share of Syntekabio is ₩6,420. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Syntekabio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Syntekabio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,073.02. Based on the TTM, the Book Value Change Per Share is ₩-65.31 per quarter. Based on the YOY, the Book Value Change Per Share is ₩82.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Syntekabio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.030.0%-0.090.0%-0.110.0%-0.090.0%-0.090.0%
Usd Book Value Change Per Share0.040.0%-0.050.0%0.060.0%0.070.0%0.070.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.040.0%-0.050.0%0.060.0%0.070.0%0.070.0%
Usd Price Per Share4.75-7.98-6.57-8.08-8.08-
Price to Earnings Ratio38.20--0.40--17.39--18.81--18.81-
Price-to-Total Gains Ratio118.19--60.06--7.93--133.46--133.46-
Price to Book Ratio3.27-4.99-4.58-5.05-5.05-
Price-to-Total Gains Ratio118.19--60.06--7.93--133.46--133.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.494
Number of shares222
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.050.07
Usd Total Gains Per Share-0.050.07
Gains per Quarter (222 shares)-10.1516.11
Gains per Year (222 shares)-40.6064.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-41-5106454
20-81-920129118
30-122-1330193182
40-162-1740258246
50-203-2150322310
60-244-2560387374
70-284-2970451438
80-325-3380515502
90-365-3790580566
100-406-4200644630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%3.017.00.015.0%3.017.00.015.0%3.017.00.015.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%7.013.00.035.0%7.013.00.035.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SyntekaBio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--57.363-65.314+214%82.498-30%103.651-45%103.651-45%
Book Value Per Share--2073.0212336.451-11%2034.294+2%2339.876-11%2339.876-11%
Current Ratio--1.0991.800-39%7.367-85%24.873-96%24.873-96%
Debt To Asset Ratio--0.4040.381+6%0.447-10%0.280+44%0.280+44%
Debt To Equity Ratio--0.6770.618+10%0.822-18%0.511+32%0.511+32%
Dividend Per Share----0%-0%-0%-0%
Eps--44.374-121.589+374%-162.440+466%-127.182+387%-127.182+387%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap97959570000.000-6%103452630000.000173870607500.000-41%143162876250.000-28%176205158000.000-41%176205158000.000-41%
Net Profit Margin--752.314720.242+4%-387.249+151%56.241+1238%56.241+1238%
Operating Margin----0%-254.2900%-55.7600%-55.7600%
Operating Ratio---444.224-100%532.729-100%195.391-100%195.391-100%
Pb Ratio3.097-6%3.2714.986-34%4.575-29%5.053-35%5.053-35%
Pe Ratio36.170-6%38.198-0.397+101%-17.393+146%-18.810+149%-18.810+149%
Price Per Share6420.000-6%6780.00011395.000-41%9382.500-28%11548.000-41%11548.000-41%
Price To Free Cash Flow Ratio----6.0660%-14.6740%-26.1770%-26.1770%
Price To Total Gains Ratio111.918-6%118.194-60.058+151%-7.933+107%-133.459+213%-133.459+213%
Quick Ratio---0.000-100%7.015-100%29.720-100%29.720-100%
Return On Assets--0.013-0.045+450%-0.050+494%-0.041+422%-0.041+422%
Return On Equity--0.021-0.078+464%-0.093+533%-0.065+405%-0.065+405%
Total Gains Per Share--57.363-65.314+214%82.498-30%103.651-45%103.651-45%
Usd Book Value--22141830.20024955516.481-11%21728193.095+2%24992099.553-11%24992099.553-11%
Usd Book Value Change Per Share--0.040-0.046+214%0.058-30%0.073-45%0.073-45%
Usd Book Value Per Share--1.4511.636-11%1.424+2%1.638-11%1.638-11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.031-0.085+374%-0.114+466%-0.089+387%-0.089+387%
Usd Free Cash Flow----3274511.2160%-1908916.4660%-2385641.9520%-2385641.9520%
Usd Market Cap68571699.000-6%72416841.000121709425.250-41%100214013.375-28%123343610.600-41%123343610.600-41%
Usd Price Per Share4.494-6%4.7467.977-41%6.568-28%8.084-41%8.084-41%
Usd Profit--473958.100-1298682.306+374%-1969457.905+516%-1405308.931+397%-1405308.931+397%
Usd Revenue--630.00021766.973-97%15898.787-96%54335.602-99%54335.602-99%
Usd Total Gains Per Share--0.040-0.046+214%0.058-30%0.073-45%0.073-45%
 EOD+3 -4MRQTTM+14 -12YOY+15 -115Y+10 -1610Y+10 -16

3.3 Fundamental Score

Let's check the fundamental score of SyntekaBio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.170
Price to Book Ratio (EOD)Between0-13.097
Net Profit Margin (MRQ)Greater than0752.314
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.099
Debt to Asset Ratio (MRQ)Less than10.404
Debt to Equity Ratio (MRQ)Less than10.677
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.013
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of SyntekaBio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.786
Ma 20Greater thanMa 505,561.500
Ma 50Greater thanMa 1005,648.500
Ma 100Greater thanMa 2006,272.650
OpenGreater thanClose6,550.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About SyntekaBio Inc

SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company. It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics. SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.

Fundamental data was last updated by Penke on 2024-11-11 08:24:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Syntekabio earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • A Net Profit Margin of 75,231.4% means that ₩752.31 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SyntekaBio Inc:

  • The MRQ is 75,231.4%. The company is making a huge profit. +2
  • The TTM is 72,024.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ75,231.4%TTM72,024.2%+3,207.3%
TTM72,024.2%YOY-38,724.9%+110,749.0%
TTM72,024.2%5Y5,624.1%+66,400.1%
5Y5,624.1%10Y5,624.1%0.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ75,231.4%-18.5%+75,249.9%
TTM72,024.2%-18.9%+72,043.1%
YOY-38,724.9%-17.7%-38,707.2%
5Y5,624.1%-30.4%+5,654.5%
10Y5,624.1%-34.1%+5,658.2%
4.3.1.2. Return on Assets

Shows how efficient Syntekabio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • 1.3% Return on Assets means that Syntekabio generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SyntekaBio Inc:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is -4.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.3%TTM-4.5%+5.7%
TTM-4.5%YOY-5.0%+0.6%
TTM-4.5%5Y-4.1%-0.4%
5Y-4.1%10Y-4.1%0.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%-3.8%+5.1%
TTM-4.5%-4.0%-0.5%
YOY-5.0%-4.5%-0.5%
5Y-4.1%-4.8%+0.7%
10Y-4.1%-5.2%+1.1%
4.3.1.3. Return on Equity

Shows how efficient Syntekabio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • 2.1% Return on Equity means Syntekabio generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SyntekaBio Inc:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -7.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.1%TTM-7.8%+9.9%
TTM-7.8%YOY-9.3%+1.5%
TTM-7.8%5Y-6.5%-1.2%
5Y-6.5%10Y-6.5%0.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-2.4%+4.5%
TTM-7.8%-4.2%-3.6%
YOY-9.3%-5.6%-3.7%
5Y-6.5%-8.0%+1.5%
10Y-6.5%-8.3%+1.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SyntekaBio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Syntekabio is operating .

  • Measures how much profit Syntekabio makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SyntekaBio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-25,429.0%+25,429.0%
TTM-5Y-5,576.0%+5,576.0%
5Y-5,576.0%10Y-5,576.0%0.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.6%+14.6%
TTM--18.4%+18.4%
YOY-25,429.0%-12.7%-25,416.3%
5Y-5,576.0%-14.8%-5,561.2%
10Y-5,576.0%-22.4%-5,553.6%
4.3.2.2. Operating Ratio

Measures how efficient Syntekabio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are ₩0.00 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of SyntekaBio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM444.224-444.224
TTM444.224YOY532.729-88.505
TTM444.2245Y195.391+248.833
5Y195.39110Y195.3910.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.277-1.277
TTM444.2241.290+442.934
YOY532.7291.385+531.344
5Y195.3911.283+194.108
10Y195.3911.311+194.080
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SyntekaBio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Syntekabio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.10 means the company has ₩1.10 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of SyntekaBio Inc:

  • The MRQ is 1.099. The company is just able to pay all its short-term debts.
  • The TTM is 1.800. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.099TTM1.800-0.701
TTM1.800YOY7.367-5.567
TTM1.8005Y24.873-23.074
5Y24.87310Y24.8730.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0991.661-0.562
TTM1.8001.731+0.069
YOY7.3671.922+5.445
5Y24.8732.645+22.228
10Y24.8732.637+22.236
4.4.3.2. Quick Ratio

Measures if Syntekabio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SyntekaBio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.0000.000
TTM0.000YOY7.015-7.015
TTM0.0005Y29.720-29.720
5Y29.72010Y29.7200.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.065-1.065
TTM0.0001.211-1.211
YOY7.0151.415+5.600
5Y29.7202.266+27.454
10Y29.7202.321+27.399
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SyntekaBio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Syntekabio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Syntekabio to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.40 means that Syntekabio assets are financed with 40.4% credit (debt) and the remaining percentage (100% - 40.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SyntekaBio Inc:

  • The MRQ is 0.404. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.381. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.381+0.023
TTM0.381YOY0.447-0.066
TTM0.3815Y0.280+0.101
5Y0.28010Y0.2800.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4040.403+0.001
TTM0.3810.407-0.026
YOY0.4470.421+0.026
5Y0.2800.423-0.143
10Y0.2800.428-0.148
4.5.4.2. Debt to Equity Ratio

Measures if Syntekabio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Syntekabio to the Health Information Services industry mean.
  • A Debt to Equity ratio of 67.7% means that company has ₩0.68 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SyntekaBio Inc:

  • The MRQ is 0.677. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.618. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.677TTM0.618+0.059
TTM0.618YOY0.822-0.205
TTM0.6185Y0.511+0.107
5Y0.51110Y0.5110.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6770.565+0.112
TTM0.6180.574+0.044
YOY0.8220.630+0.192
5Y0.5110.624-0.113
10Y0.5110.649-0.138
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Syntekabio generates.

  • Above 15 is considered overpriced but always compare Syntekabio to the Health Information Services industry mean.
  • A PE ratio of 38.20 means the investor is paying ₩38.20 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SyntekaBio Inc:

  • The EOD is 36.170. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.198. Based on the earnings, the company is overpriced. -1
  • The TTM is -0.397. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD36.170MRQ38.198-2.028
MRQ38.198TTM-0.397+38.595
TTM-0.397YOY-17.393+16.997
TTM-0.3975Y-18.810+18.413
5Y-18.81010Y-18.8100.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD36.170-1.139+37.309
MRQ38.198-1.109+39.307
TTM-0.397-1.532+1.135
YOY-17.393-2.409-14.984
5Y-18.810-3.924-14.886
10Y-18.810-4.283-14.527
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SyntekaBio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-6.066+6.066
TTM-6.066YOY-14.674+8.608
TTM-6.0665Y-26.177+20.111
5Y-26.17710Y-26.1770.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.113+1.113
TTM-6.066-1.629-4.437
YOY-14.674-3.058-11.616
5Y-26.177-6.736-19.441
10Y-26.177-4.328-21.849
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Syntekabio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 3.27 means the investor is paying ₩3.27 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of SyntekaBio Inc:

  • The EOD is 3.097. Based on the equity, the company is fair priced.
  • The MRQ is 3.271. Based on the equity, the company is fair priced.
  • The TTM is 4.986. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.097MRQ3.271-0.174
MRQ3.271TTM4.986-1.716
TTM4.986YOY4.575+0.411
TTM4.9865Y5.053-0.067
5Y5.05310Y5.0530.000
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD3.0971.636+1.461
MRQ3.2711.752+1.519
TTM4.9861.764+3.222
YOY4.5752.235+2.340
5Y5.0533.864+1.189
10Y5.0534.228+0.825
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -3,228,040-4,649-3,232,689437,353-2,795,336-415,069-3,210,4053,211,305900



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets53,030,278
Total Liabilities21,399,092
Total Stockholder Equity31,631,186
 As reported
Total Liabilities 21,399,092
Total Stockholder Equity+ 31,631,186
Total Assets = 53,030,278

Assets

Total Assets53,030,278
Total Current Assets20,846,819
Long-term Assets32,183,459
Total Current Assets
Total Current Assets  (as reported)20,846,819
Total Current Assets  (calculated)0
+/- 20,846,819
Long-term Assets
Long-term Assets  (as reported)32,183,459
Long-term Assets  (calculated)0
+/- 32,183,459

Liabilities & Shareholders' Equity

Total Current Liabilities18,969,619
Long-term Liabilities2,429,473
Total Stockholder Equity31,631,186
Total Current Liabilities
Total Current Liabilities  (as reported)18,969,619
Total Current Liabilities  (calculated)0
+/- 18,969,619
Long-term Liabilities
Long-term Liabilities  (as reported)2,429,473
Long-term Liabilities  (calculated)0
+/- 2,429,473
Total Stockholder Equity
Total Stockholder Equity (as reported)31,631,186
Total Stockholder Equity (calculated)0
+/- 31,631,186
Other
Common Stock Shares Outstanding 15,258
Net Invested Capital 31,631,186
Net Working Capital 1,877,200



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
> Total Assets 
0
30,240,317
47,946,292
46,860,999
46,502,191
45,125,798
44,777,916
44,320,069
42,930,487
39,852,818
67,879,161
64,466,340
59,842,220
57,851,426
55,688,724
54,286,319
56,592,515
76,121,755
52,916,638
47,554,094
53,030,278
53,030,27847,554,09452,916,63876,121,75556,592,51554,286,31955,688,72457,851,42659,842,22064,466,34067,879,16139,852,81842,930,48744,320,06944,777,91645,125,79846,502,19146,860,99947,946,29230,240,3170
   > Total Current Assets 
0
27,885,811
45,656,252
44,346,501
42,857,968
41,489,942
41,536,380
41,321,990
33,747,344
30,418,385
58,193,453
54,946,345
44,122,907
41,833,505
37,496,886
35,403,208
34,973,316
49,304,463
21,979,529
15,557,235
20,846,819
20,846,81915,557,23521,979,52949,304,46334,973,31635,403,20837,496,88641,833,50544,122,90754,946,34558,193,45330,418,38533,747,34441,321,99041,536,38041,489,94242,857,96844,346,50145,656,25227,885,8110
       Cash And Cash Equivalents 
0
546,241
17,217,056
5,193,112
2,868,418
1,820,036
2,650,503
12,845,958
232
322
13,708,513
178
0
0
35,342,065
33,077,771
30,314,209
32,882,377
19,667,721
13,817,063
0
013,817,06319,667,72132,882,37730,314,20933,077,77135,342,0650017813,708,51332223212,845,9582,650,5031,820,0362,868,4185,193,11217,217,056546,2410
       Short-term Investments 
0
0
0
0
0
0
38,440,000
27,940,000
25,440,000
25,440,000
39,000,000
23,000,000
5,000,000
0
0
0
1
0
0
0
0
000010005,000,00023,000,00039,000,00025,440,00025,440,00027,940,00038,440,000000000
       Net Receivables 
0
158,188
172,016
332,265
308,591
414,599
273,760
310,146
150,984
195,044
158,270
209,879
69,951
92,907
112,915
105,865
77,390
460
245
333
0
033324546077,390105,865112,91592,90769,951209,879158,270195,044150,984310,146273,760414,599308,591332,265172,016158,1880
       Other Current Assets 
0
5,000
106,616
124,817
90,584
168,097
96,914
141,850
13,133
6,213
5,038,538
3,854,988
1,518,214
1,533,133
1,520,300
2,028,556
4,088,147
0
0
0
0
00004,088,1472,028,5561,520,3001,533,1331,518,2143,854,9885,038,5386,21313,133141,85096,914168,09790,584124,817106,6165,0000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,191,838
18,883,111
21,619,199
26,817,292
30,937,109
31,996,859
32,183,459
32,183,45931,996,85930,937,10926,817,29221,619,19918,883,11118,191,83800000000000000
       Property Plant Equipment 
971,668
1,721,677
1,740,975
1,959,101
2,986,572
3,060,260
2,581,871
2,358,067
8,538,227
8,809,693
9,054,462
8,854,245
14,940,013
15,128,778
17,474,641
18,256,628
21,101,145
26,320,775
30,461,382
31,540,531
0
031,540,53130,461,38226,320,77521,101,14518,256,62817,474,64115,128,77814,940,0138,854,2459,054,4628,809,6938,538,2272,358,0672,581,8713,060,2602,986,5721,959,1011,740,9751,721,677971,668
       Intangible Assets 
0
490,255
486,491
472,823
495,077
483,022
475,020
452,347
466,631
445,835
432,981
407,672
571,286
672,845
631,993
539,078
485,986
463,830
443,848
423,407
0
0423,407443,848463,830485,986539,078631,993672,845571,286407,672432,981445,835466,631452,347475,020483,022495,077472,823486,491490,2550
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000
> Total Liabilities 
0
1,686,844
1,835,643
1,915,027
2,913,672
2,885,200
3,237,824
4,367,461
4,287,483
3,520,327
40,251,983
37,287,373
29,259,837
29,576,329
24,227,949
25,478,645
20,974,957
27,134,188
21,688,348
16,798,185
21,399,092
21,399,09216,798,18521,688,34827,134,18820,974,95725,478,64524,227,94929,576,32929,259,83737,287,37340,251,9833,520,3274,287,4834,367,4613,237,8242,885,2002,913,6721,915,0271,835,6431,686,8440
   > Total Current Liabilities 
0
586,697
713,214
748,563
761,254
760,406
1,037,372
2,104,744
2,057,195
1,555,500
1,888,384
1,984,087
1,764,267
1,712,976
22,254,407
23,449,779
18,906,172
12,671,041
19,398,295
14,466,463
18,969,619
18,969,61914,466,46319,398,29512,671,04118,906,17223,449,77922,254,4071,712,9761,764,2671,984,0871,888,3841,555,5002,057,1952,104,7441,037,372760,406761,254748,563713,214586,6970
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,453,665
11,164,295
7,771,364
4,488,891
1,803,468
1,996,464
0
01,996,4641,803,4684,488,8917,771,36411,164,29510,453,66500000000000000
       Other Current Liabilities 
0
0
281,833
395,456
225,670
171,896
286,196
1,464,516
0
0
0
0
1,231,887
1,104,609
11,136,487
11,676,831
1
0
0
0
0
0000111,676,83111,136,4871,104,6091,231,88700001,464,516286,196171,896225,670395,456281,83300
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,973,543
2,028,866
2,068,785
14,463,147
2,290,053
2,331,722
2,429,473
2,429,4732,331,7222,290,05314,463,1472,068,7852,028,8661,973,54300000000000000
       Long term Debt Total 
0
199,169
150,228
129,495
1,023,833
932,771
552,244
502,698
431,976
300,234
8,637,365
9,132,122
9,676,434
10,192,756
251,645
187,539
126,988
0
0
0
0
0000126,988187,539251,64510,192,7569,676,4349,132,1228,637,365300,234431,976502,698552,244932,7711,023,833129,495150,228199,1690
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
666,840
583,500
489,708
396,579
290,607
192,738
0
0192,738290,607396,579489,708583,500666,84000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
001000000000000000000
> Total Stockholder Equity
0
28,553,473
46,110,649
44,945,973
43,588,519
42,240,598
41,540,092
39,952,607
38,643,004
36,332,491
27,627,178
27,178,967
30,582,382
28,275,097
31,460,775
28,807,674
35,617,558
48,987,566
31,228,290
30,755,909
31,631,186
31,631,18630,755,90931,228,29048,987,56635,617,55828,807,67431,460,77528,275,09730,582,38227,178,96727,627,17836,332,49138,643,00439,952,60741,540,09242,240,59843,588,51944,945,97346,110,64928,553,4730
   Common Stock
1,998,092
5,753,438
6,577,438
6,586,818
6,621,008
6,621,008
6,681,008
6,702,008
6,750,008
6,750,008
6,750,008
6,757,758
6,758,858
6,758,858
6,758,858
6,760,858
7,219,889
0
0
0
0
00007,219,8896,760,8586,758,8586,758,8586,758,8586,757,7586,750,0086,750,0086,750,0086,702,0086,681,0086,621,0086,621,0086,586,8186,577,4385,753,4381,998,092
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 
0
52,175,518
70,142,955
71,171,861
71,454,584
71,649,351
73,221,738
73,482,518
73,427,531
73,427,531
73,427,531
73,642,706
73,673,041
73,673,041
80,932,616
73,699,073
88,319,276
0
0
0
0
000088,319,27673,699,07380,932,61673,673,04173,673,04173,642,70673,427,53173,427,53173,427,53173,482,51873,221,73871,649,35171,454,58471,171,86170,142,95552,175,5180
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
1,177,335
787,122
961,278
942,010
893,374
1,040,616
1,235,836
1,135,370
-351,381
-351,381
-2,168
10,030
726,665
1,105,835
1,220,947
8,754,006
76,000
0
0
0
0
000076,0008,754,0061,220,9471,105,835726,66510,030-2,168-351,381-351,3811,135,3701,235,8361,040,616893,374942,010961,278787,1221,177,335



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue123,406
Cost of Revenue-0
Gross Profit123,406123,406
 
Operating Income (+$)
Gross Profit123,406
Operating Expense-12,399,704
Operating Income-12,276,298-12,276,298
 
Operating Expense (+$)
Research Development3,224,838
Selling General Administrative1,610,604
Selling And Marketing Expenses0
Operating Expense12,399,7044,835,442
 
Net Interest Income (+$)
Interest Income1,171,130
Interest Expense-375,744
Other Finance Cost-603,079
Net Interest Income192,307
 
Pretax Income (+$)
Operating Income-12,276,298
Net Interest Income192,307
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,397,645-12,276,298
EBIT - interestExpense = -375,744
-11,397,645
-11,021,901
Interest Expense375,744
Earnings Before Interest and Taxes (EBIT)0-11,021,901
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-11,397,645
Tax Provision-0
Net Income From Continuing Ops-11,397,645-11,397,645
Net Income-11,397,645
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-192,307
 

Technical Analysis of Syntekabio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Syntekabio. The general trend of Syntekabio is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Syntekabio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SyntekaBio Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 7,080 < 7,790 < 7,940.

The bearish price targets are: 6,300 > 6,160 > 4,195.

Tweet this
SyntekaBio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SyntekaBio Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SyntekaBio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SyntekaBio Inc. The current macd is 272.82.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Syntekabio price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Syntekabio. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Syntekabio price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SyntekaBio Inc Daily Moving Average Convergence/Divergence (MACD) ChartSyntekaBio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SyntekaBio Inc. The current adx is 25.80.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Syntekabio shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
SyntekaBio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SyntekaBio Inc. The current sar is 5,829.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
SyntekaBio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SyntekaBio Inc. The current rsi is 60.79. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
SyntekaBio Inc Daily Relative Strength Index (RSI) ChartSyntekaBio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SyntekaBio Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Syntekabio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
SyntekaBio Inc Daily Stochastic Oscillator ChartSyntekaBio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SyntekaBio Inc. The current cci is 119.79.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
SyntekaBio Inc Daily Commodity Channel Index (CCI) ChartSyntekaBio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SyntekaBio Inc. The current cmo is 25.20.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SyntekaBio Inc Daily Chande Momentum Oscillator (CMO) ChartSyntekaBio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SyntekaBio Inc. The current willr is -40.1826484.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Syntekabio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SyntekaBio Inc Daily Williams %R ChartSyntekaBio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SyntekaBio Inc.

SyntekaBio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SyntekaBio Inc. The current atr is 534.37.

SyntekaBio Inc Daily Average True Range (ATR) ChartSyntekaBio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SyntekaBio Inc. The current obv is 78,131,711.

SyntekaBio Inc Daily On-Balance Volume (OBV) ChartSyntekaBio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SyntekaBio Inc. The current mfi is 77.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
SyntekaBio Inc Daily Money Flow Index (MFI) ChartSyntekaBio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SyntekaBio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

SyntekaBio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SyntekaBio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.786
Ma 20Greater thanMa 505,561.500
Ma 50Greater thanMa 1005,648.500
Ma 100Greater thanMa 2006,272.650
OpenGreater thanClose6,550.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Syntekabio with someone you think should read this too:
  • Are you bullish or bearish on Syntekabio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Syntekabio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SyntekaBio Inc

I send you an email if I find something interesting about SyntekaBio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about SyntekaBio Inc.

Receive notifications about SyntekaBio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.